Effect of AQW051 in Patients With Memory Impairment
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will investigate AQW051 in patients with either mild Alzheimer's disease or
amnestic mild cognitive impairment. The effect on cognitive impairment will be measure using
validated computerized tests which measure cognitive function. This study will also explore
the safety and tolerability of AQW051 in these patients.